Hanh Nguyen
Primary Care · Bear, DENPI 1790495240
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations.
Across 64 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$189
- AstraZeneca$171
- Lilly USA, LLC$152
- Exact Sciences$114
- Dexcom, Inc.$80
- Indivior Inc.$76
- plus $424 from 16 others
What the payments were for
- Food & beverage$1,207100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $189 |
| AstraZeneca | 11 | $171 |
| Lilly USA, LLC | 8 | $152 |
| Exact Sciences | 5 | $114 |
| Dexcom, Inc. | 3 | $80 |
| Indivior Inc. | 4 | $76 |
| Novo Nordisk | 3 | $55 |
| Hologic Sales And Service, LLC | 2 | $48 |
| Shield Therapeutics Inc | 2 | $41 |
| Sanofi-aventis U.S. LLC | 1 | $38 |
| Pfizer | 2 | $34 |
| Merck | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Tactile Systems Technology Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Amgen | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
| Braeburn Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Medtronic | 1 | $13 |
How this compares
$1,207 in reported general payments places this provider in the 65th percentile of 25 primary care providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $988 |
| Atorvastatin Calcium | 45 | $664 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $317 |
| Losartan Potassium | 29 | $244 |
| Omeprazole | 24 | $220 |
| Metformin Hcl | 46 | $208 |
| Rosuvastatin Calcium | 18 | $188 |
| Fluticasone Propionate | 11 | $185 |
| Lisinopril | 15 | $142 |
| Amlodipine Besylate | 30 | $120 |
| Levothyroxine Sodium | 11 | $115 |
| Montelukast Sodium | 13 | $99 |
Paid to pharmacies, not to this prescriber.
Other primary care in Bear
- Andrea BoyleBear$55
- Florence AkouegnonWilmington$5K
- Catherine SlaughWilmington$4K
- Cynthia Lang-GroeningWilmington$3K
- Hardi PatelDover$3K
- Rachael OfiliNewark$2K
- Hannah HierlmaierDover$1K
- Julie MbuaWilmington$1K
- Lisa StaabGeorgetown$1K
- Christina RiceWilmington$618
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.